New Jersey Division of Consumer Affairs Statewide Integration
The New Jersey Prescription Monitoring Program (NJPMP) is an important component of the New Jersey Division of Consumer Affairs' initiative to halt the abuse and diversion of prescription drugs.
Established pursuant to N.J.S.A. 45:1-45 et. seq., the NJPMP is a statewide database that collects prescription data on Controlled Dangerous Substances (CDS), Human Growth Hormone (HGH), and gabapentin dispensed in outpatient settings in New Jersey, and by out-of-State pharmacies dispensing into New Jersey.
The Division of Consumer Affairs and the NJPMP Administrator keep patient information strictly confidential, in compliance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy and Security Rules.
The NJPMP is capable of integration with electronic health records (EHRs) and pharmacy management systems (PMS). With integration, prescribers and pharmacists will be able to seamlessly access patients' NJPMP reports at the point-of-care within their primary clinical workflow software programs. The State is utilizing an integration service called PMP Gateway that is operated by Appriss Health.